The cost of Spravato (esketamine nasal spray) can vary significantly based on insurance coverage, dosage, and the healthcare setting where it is administered. The list price for Spravato is approximately $600 per treatment, but this does not reflect the actual out-of-pocket cost for patients [1].
How is Spravato administered and how does that affect cost?
Spravato is administered in a certified healthcare setting due to the potential for sedation and dissociation. This requires a period of observation after administration, which can contribute to the overall cost of treatment [2]. Patients must remain at the certified healthcare facility for at least two hours after taking the medication and be monitored for at least another hour post-dose [3].
What financial assistance is available for Spravato?
Janssen Pharmaceutical Companies, the manufacturer of Spravato, offers a savings program. For eligible commercially insured patients, the out-of-pocket cost could be as low as $0 for the medication per month, with a maximum annual out-of-pocket spending limit [4]. This program is managed by the Janssen CarePath program [5].
Does insurance cover Spravato?
Coverage for Spravato varies among insurance providers. Many insurance plans may require prior authorization or have specific criteria that must be met for coverage. Patients are advised to check with their insurance provider regarding their specific plan benefits for Spravato [6].
What are the potential risks associated with Spravato treatment?
Spravato carries risks that necessitate administration in a certified healthcare setting. These risks include sedation, dissociation, and potential for abuse or misuse. Patients may also experience increased blood pressure, which requires monitoring [2][3].
How does Spravato work for treatment-resistant depression?
Spravato is a non-MAO (monoamine oxidase inhibitor) antidepressant that works differently from traditional antidepressants. It is thought to rapidly increase levels of glutamate, a neurotransmitter, which helps to quickly restore synaptic connections in the brain, improving mood and reducing suicidal thoughts [3][7]. It is indicated for adults with treatment-resistant depression (TRD) and depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior [2].
When does the patent for Spravato expire?
Information regarding specific patent expiry dates for Spravato is complex, as it can involve multiple patents related to the compound, formulation, and methods of use. For detailed patent information and timelines, resources such as DrugPatentWatch.com can provide specific data [8].